Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-196-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Based on the available data, a theoretical assessment of the toxicokinetic behaviour of the test substance was performed.
The substance has a low bioaccumulation potential and for risk assessment purposes, 100% is used for oral, dermal and inhalation absorption.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
A substance can enter the body via the gastrointestinal tract, the lungs, or the skin, depending on the exposure route. After oral administration, in general, a compound needs to be dissolved before it can be taken up from the gastro-intestinal tract. GPM-800 dissolves in water (62 g/L (at 20°C), therefore it is expected to readily dissolve into the gastrointestinal fluids. In principle, this would allow passive diffusion (passage of small water-soluble molecules through aqueous pores or carriage of such molecules across membranes with the bulk passage of water). GPM-800 is a polymeric mercaptan with a considerable size range (appr. 490 -1474 g/mol). As absorption is estimated to be still possible via this route for molecules with a molecular weight below 1000, some uptake via passive diffusion is expected for GPM-800. Furthermore, the substance dissolves in n-octanol, which results in a moderate to high partition coefficient (log Pow > 1.2 (at 20°C)). This lipophilic characteristic favors absorption by passive diffusion. The hydrolysis rate is slow (t1/2 > 1 year at 25°C at pH 4, 7 and 9) and is not further expected to influence the uptake. In conclusion, its solubility in water, its moderate to high partition coefficient and its molecular size will allow oral absorption. For risk assessment purposes oral absorption of GPM-800 is therefore set at 100% . The oral toxicity data do not provide reason to deviate from the proposed oral absorption factor. Once absorbed, wide distribution of GPM-800 throughout the body is expected based on its water solubility and its molecular weight range. As GPM-800 dissolves both in water and in n-octanol, it is expected not to have a special preference for fatty tissues. GPM-800 is expected to be excreted via urine. Based on these considerations, GPM-800 is not expected to bio-accumulate significantly in the body upon exposure. GPM-800 is a liquid with low volatility, as reflected in a low vapour pressure (0.16 Pa at 20°C) and absence of a boiling point (substance decomposes at ≥320°C). This implies that exposure via inhalation of vapour of GPM-800 is not likely to occur. However, liquid aerosols can be formed, which can be inhaled. Once GPM-800 reaches the lung tissue, it will readily dissolve in the mucus lining of the respiratory tract. The moderate to high lipohilicity allows the substance to cross the alveolar and capillary membranes by passive diffusion and be absorbed. Based on the above data, for risk assessment purposes the inhalation absorption of GPM-800 is set at 100%. In general, liquids such as GPM-800 are taken up more readily than dry particulates. In order to cross the skin, a compound must first penetrate into the stratum corneum (non-viable layer of corneocytes forming a complex lipid membrane) and subsequently reaches the viable epidermis, the dermis and the vascular network. The stratum corneum provides its greatest barrier function against hydrophilic compounds, whereas the viable epidermis is most resistant to penetration by highly lipophilic compounds. The combined characteristics of moderate water solubility and moderate to high lipophilicity of GPM-800 enables the substance to cross both barriers. Therefore dermal absorption is likely to be high. GPM-800 is surface active, with a surface tension of 29.9 mN/m (at 20°C, at 250 mg/L). However at this value, this characteristic is not expected to be of major influence on the uptake (only surfactants which reduce the surface tension of an aqueous solution < 10 mN/m are expected to enhance dermal uptake). On the other hand, the molecular size of GPM-800 (appr. 490 -1474 g/mol; representative size 800 g/mole) is expected to hamper dermal absorption as it may be too large for uptake across biomembranes. According to the criteria given in the REACH Guidance, 10% dermal absorption will be considered in case MW >500 and log Pow <-1 or >4, otherwise 100% dermal absorption should be used. Both the molecular weight of GPM-800 (approx. 490 -1474 g/mol) and the moderate partition coefficient do not meet the criteria for limited dermal absorption. Therefore, for risk assessment purposes dermal absorption is set at 100%.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
